GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » Cash Conversion Cycle

Shanghai Pioneer Holding (HKSE:01345) Cash Conversion Cycle : 138.13 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Shanghai Pioneer Holding's Days Sales Outstanding for the six months ended in Dec. 2023 was 100.92.
Shanghai Pioneer Holding's Days Inventory for the six months ended in Dec. 2023 was 136.91.
Shanghai Pioneer Holding's Days Payable for the six months ended in Dec. 2023 was 99.7.
Therefore, Shanghai Pioneer Holding's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 138.13.


Shanghai Pioneer Holding Cash Conversion Cycle Historical Data

The historical data trend for Shanghai Pioneer Holding's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding Cash Conversion Cycle Chart

Shanghai Pioneer Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 175.37 125.36 100.01 89.31 127.89

Shanghai Pioneer Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.40 108.38 85.71 123.25 138.13

Competitive Comparison of Shanghai Pioneer Holding's Cash Conversion Cycle

For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pioneer Holding's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Shanghai Pioneer Holding's Cash Conversion Cycle falls into.



Shanghai Pioneer Holding Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Shanghai Pioneer Holding's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=101.37+151.5-124.98
=127.89

Shanghai Pioneer Holding's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=100.92+136.91-99.7
=138.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pioneer Holding  (HKSE:01345) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Shanghai Pioneer Holding Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pioneer Holding (HKSE:01345) Business Description

Traded in Other Exchanges
N/A
Address
No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331
Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.
Executives
Bank Of Communications Trustee Limited 2301 Trustee
Pioneer Pharma (bvi) Co.,ltd 2101 Beneficial owner
Tian Tian Limited 2201 Interest of corporation controlled by you
Li Xinzhou 2202 Interest of your spouse
Wu Qian 2201 Interest of corporation controlled by you

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines